PubRank

C Vivas

Author PubWeight™ 53.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 1995 2.09
2 Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999 1.93
3 Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc 1993 1.72
4 An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant 2001 1.48
5 Pancreas transplantation with enteric drainage under tacrolimus induction therapy. Transplant Proc 1997 1.48
6 Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism. Transplantation 1995 1.19
7 Tacrolimus in pediatric renal transplantation. Transplantation 1996 1.18
8 A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. Clin Transplant 1994 1.15
9 A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation 1999 1.14
10 A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc 1995 1.13
11 FK506 in pediatric kidney transplantation--primary and rescue experience. Pediatr Nephrol 1995 1.11
12 Tacrolimus in renal transplantation. Transplant Proc 1996 1.10
13 Biopsy of marginal donor kidneys: correlation of histologic findings with graft dysfunction. Transplantation 2000 1.05
14 Enteric drainage of pancreas transplants revisited. Transplant Proc 1995 1.03
15 Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation 1999 1.00
16 Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. Transplant Proc 1997 0.98
17 Combined simultaneous kidney/bone marrow transplantation. Transplantation 1995 0.98
18 Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999 0.96
19 Interferon-alpha-induced acute renal allograft rejection. Transplantation 1995 0.95
20 Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff Schema. Transplantation 1997 0.92
21 Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 1998 0.91
22 Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. Clin Transplant 1997 0.90
23 Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 2000 0.87
24 Pediatric kidney transplantation at the University of Pittsburgh. Transplant Proc 1994 0.86
25 Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc 1993 0.85
26 The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. Clin Transpl 1995 0.85
27 Renal transplantation under FK 506 in African-Americans: early experience. Transplant Proc 1993 0.83
28 Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Transplantation 1999 0.83
29 Tacrolimus nephrotoxicity after renal transplantation. Transplant Proc 1997 0.83
30 FK 506 in the management of nephrotic syndrome after renal transplantation. Transplant Proc 1993 0.83
31 Improving results of pediatric renal transplantation. J Am Coll Surg 1994 0.82
32 "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. Transplantation 1996 0.82
33 Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. Transplant Proc 1991 0.82
34 Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation 1999 0.82
35 Reducing the length of stay after kidney transplantation--the intensive outpatient unit. Clin Transplant 1998 0.82
36 Pancreas transplantation without antibody therapy. Transplant Proc 1998 0.80
37 Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy. Transplant Proc 1997 0.80
38 Initial pleural pressure measurement in spontaneous pneumothorax. Lung 2000 0.79
39 Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. Transplant Proc 1999 0.78
40 Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization. Transplantation 1999 0.78
41 Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). Am J Surg Pathol 2000 0.78
42 Renal transplantation at the University of Pittsburgh: the impact of FK506. Clin Transpl 1994 0.78
43 Effect of chronic noise or water restriction on weight of body and organs in the rat. Rev Esp Fisiol 1983 0.77
44 Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression. Transplant Proc 2001 0.76
45 Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. Transplant Proc 1995 0.76
46 A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol 1998 0.75
47 Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc 1993 0.75
48 Tacrolimus-based immunosuppression in pediatric renal transplantation. Transplant Proc 1999 0.75
49 Tacrolimus rescue therapy for renal transplant rejection. Transplant Proc 1996 0.75
50 Posttransplant hypertension in blacks versus nonblacks. Transplant Proc 1993 0.75
51 Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 2001 0.75
52 Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder. Clin Transplant 1997 0.75
53 Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh. Transplant Proc 1993 0.75
54 Posttransplant diabetes in pediatric recipients on tacrolimus. Transplantation 1999 0.75
55 Outcome of kidney transplantation in African-Americans using tacrolimus. Transplant Proc 1997 0.75
56 Alopecia as a consequence of tacrolimus therapy. Transplantation 1998 0.75
57 Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients. Transplant Proc 1995 0.75
58 A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. Transplant Proc 1999 0.75
59 Inability of effluent hyaluronic acid levels to predict early graft function in clinical renal transplantation. Transplantation 1993 0.75
60 Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. Transplant Proc 2000 0.75
61 Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. J Transpl Coord 1999 0.75
62 The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults. J Clin Pharmacol 1995 0.75
63 [Chagas disease: another cause of cerebral mass occurring in patients with acquired immunodeficiency syndrome]. Enferm Infecc Microbiol Clin 2000 0.75
64 Cytomegalovirus infection of the native ureter after liver-kidney transplantation. Urology 1999 0.75
65 [Primary cerebral lymphoma with negative SPECT in a patient with AIDS]. Enferm Infecc Microbiol Clin 1998 0.75
66 Pediatric urethral reconstruction without proximal diversion. J Urol 1986 0.75
67 Retrograde transurethral balloon dilation of prostate: innovative management of abacterial chronic prostatitis and prostatodynia. Urology 1990 0.75